| 标题 |
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial |
| 网址 | |
| DOI |
10.1093/bjd/ljag109
doi
|
| 其它 |
期刊:British Journal of Dermatology 作者:Brett King; B. Ehst; Peter Foley; Pascal Reygagne; Manabu Ohyama; et al 出版日期:2026-03-21 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)